Authors: Newman M.B.; Emerich D.F.; Borlongan C.V.; Sanberg C.D.; Sanberg P.R.

Source: Current Neurovascular Research, Volume 1, Number 3, July 2004 , pp. 269-281(13)

Publisher: Bentham Science Publishers

Abstract:

Neurodegenerative diseases as well as acute center nervous system (CNS) injuries remains a problematic and frustrating area of medicine in terms of treatments and cures, which is mostly due to the complex circuitry of the CNS along with our limited knowledge. Therapeutically, the last two and a half decades have offered new hope for those suffering from neurodegenerative diseases or injuries with advent of new drug discoveries and cellular therapies. Cell transplantation is a compelling and potential treatment for certain neurological and neurodegenerative diseases as well as for acute injuries to the spinal cord and brain. The hematopoietic system offers an alternative source of cells that is easily obtainable, abundant, and reliable when compared to cells obtained from fetal or embryonic origins. Human umbilical cord blood (HUCB) cells have been used clinically for over ten years to treat both malignant and non-malignant diseases. With in the last five years these cells have been used pre-clinically in animal models of brain and spinal cord injuries, in which functional recovery have been shown. This paper reviews the advantages, utilization, and progress of HUCB cells in the field of cellular transplantation and repair.

Keywords: human umbilical cord blood cells; neurodegeneration; neural stem cells; cell replacement; traumatic brain injury; spinal cord injury; als; transplantation; neural and neuronal phenotypes; immunocytochemistry

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1567202043362261

Affiliations: 1: University of South, College of Medicine MDC-78, Center of Excellence for Aging and Brain Repair, Tampa, Fl 33612, USA

Publication date: 2004-07-01

More about this publication?

• Current Neurovascular Research (CNR) provides a cross platform for the publication of scientifically rigorous research that addresses disease mechanisms of both neuronal and vascular origins in neuroscience. The journal serves as an international forum for the publication of novel and pioneering original work as well as timely neuroscience research reviews in the disciplines of cell developmental disorders, plasticity, and degeneration that bridge the gap between basic science research and clinical discovery. CNR emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.

Related content

• In this: publication
• By this: publisher
• In this Subject: Neurology & Psychiatry
• By this author: Newman M.B. ;  Emerich D.F. ;  Borlongan C.V. ;  Sanberg C.D. ;  Sanberg P.R.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers